Category: Kevin Outterson

Germ-pocalypse on the Horizon?

The Epoch Times Kevin Outterson, School of Law Researchers in China have made a truly frightening discovery. They found a gene in an E. coli bacteria that programs the bacteria to be resistant to colistin, which is commonly used as a “last resort” antibiotic for difficult to treat infections… Expert quote: “[Private] companies have been leaned […]

$1 Daraprim Alternative? Not So Fast

MedPage Today Kevin Outterson, School of Law A San Diego compounding pharmacy says it plans to come to patients’ rescue by offering a cheaper version of the antiparasite drug Daraprim (pyrimethamine), whose price skyrocketed overnight this summer, but the pharmacy may be skating on thin ice with the FDA… Expert quote: “This is a unique […]

Experts Media Alert – SCOTUS to rule on King v. Burwell

For the second time in three years, the Supreme Court is set to rule on a question which challenges the Affordable Care Act (ACA). In March, the court heard arguments on the case King v. Burwell, which deals with a unanimous federal appeals court ruling that upheld Internal Revenue Service regulations allowing health-insurance tax credits under the ACA for […]

The drug push

Science Magazine Kevin Outterson, School of Law This past January, microbiologists Kim Lewis and Slava Epstein reported the discovery of teixobactin, a compound that in lab dishes kills several antibiotic-resistant strains of bacteria. Media outlets heralded the discovery, announced in Nature, as a new solution to the growing problem of antimicrobial resistance… Expert quote: “For […]